Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe latest history entry is updated to Revision: v3.6.3, replacing the previous v3.6.2. This is an administrative update to the history list and does not modify study data or user-facing content.SummaryDifference0.1%

- Check8 days agoChange DetectedA new revision entry 'Revision: v3.6.2' was added to the study record history, and the older entry 'Revision: v3.6.0' was removed. This updates the history to reflect the latest revision labeling for the record.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRecruitment status updated to no longer look for participants, signaling enrollment closure. A new revision tag v3.6.0 was added and the previous tag v3.5.5 was removed.SummaryDifference0.4%

- Check29 days agoChange DetectedA new revision entry 'Revision: v3.5.5' is added to the study record history, replacing the previous 'Revision: v3.5.4'. This reflects an updated revision of the ClinicalTrials.gov page history.SummaryDifference0.1%

- Check50 days agoChange DetectedA new site revision entry, v3.5.4, was added to the record history, replacing the previous revision v3.5.3. This indicates a small update to the page's backend/metadata rather than content changes.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page footer/update indicator was updated from revision v3.5.2 to v3.5.3, reflecting a site software version change rather than a change to the clinical trial record.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.